• Made available online as an Accepted Preprint 2 March 2009
  • Accepted Preprint first posted online on 2 March 2009

The biology of activin: recent advances in structure, regulation and function

  1. Alan L Schneyer1
  1. Program in Membrane Biology and Division of Nephrology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    1Pioneer Valley Life Science Institute and University of Massachusetts-Amherst, 3601 Main Street, Springfield, Massachusetts 01107, USA
  1. (Correspondence should be addressed to A L Schneyer; Email: alan.schneyer{at}bhs.org)

Abstract

Activin was discovered in the 1980s as a gonadal protein that stimulated FSH release from pituitary gonadotropes and was thought of as a reproductive hormone. In the ensuing decades, many additional activities of activin were described and it was found to be produced in a wide variety of cell types at nearly all stages of development. Its signaling and actions are regulated intracellularly and by extracellular antagonists. Over the past 5 years, a number of important advances have been made that clarify our understanding of the structural basis for signaling and regulation, as well as the biological roles of activin in stem cells, embryonic development and in adults. These include the crystallization of activin in complex with the activin type II receptor ActRIIB, or with the binding proteins follistatin and follistatin-like 3, as well as identification of activin's roles in gonadal sex development, follicle development, luteolysis, β-cell proliferation and function in the islet, stem cell pluripotency and differentiation into different cell types and in immune cells. These advances are reviewed to provide perspective for future studies.

  • Received in final form 13 February 2009
  • Accepted 2 March 2009
| Table of Contents